AU2003296878A1 - Methods to administer epothilone d - Google Patents

Methods to administer epothilone d

Info

Publication number
AU2003296878A1
AU2003296878A1 AU2003296878A AU2003296878A AU2003296878A1 AU 2003296878 A1 AU2003296878 A1 AU 2003296878A1 AU 2003296878 A AU2003296878 A AU 2003296878A AU 2003296878 A AU2003296878 A AU 2003296878A AU 2003296878 A1 AU2003296878 A1 AU 2003296878A1
Authority
AU
Australia
Prior art keywords
epothilone
administer
methods
administer epothilone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003296878A
Other languages
English (en)
Other versions
AU2003296878A8 (en
Inventor
Alison Hannah
Robert G. Johnson
Michael Sherrill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kosan Biosciences Inc
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Publication of AU2003296878A1 publication Critical patent/AU2003296878A1/en
Publication of AU2003296878A8 publication Critical patent/AU2003296878A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003296878A 2002-05-20 2003-05-20 Methods to administer epothilone d Abandoned AU2003296878A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38216602P 2002-05-20 2002-05-20
US60/382,166 2002-05-20
PCT/US2003/017921 WO2004103267A2 (en) 2002-05-20 2003-05-20 Methods to administer epothilone d

Publications (2)

Publication Number Publication Date
AU2003296878A1 true AU2003296878A1 (en) 2004-12-13
AU2003296878A8 AU2003296878A8 (en) 2009-01-08

Family

ID=33476529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003296878A Abandoned AU2003296878A1 (en) 2002-05-20 2003-05-20 Methods to administer epothilone d

Country Status (7)

Country Link
US (1) US20040072882A1 (cg-RX-API-DMAC7.html)
EP (1) EP1575556A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006514681A (cg-RX-API-DMAC7.html)
KR (1) KR20050043796A (cg-RX-API-DMAC7.html)
CN (1) CN101389334A (cg-RX-API-DMAC7.html)
AU (1) AU2003296878A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004103267A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE350383T1 (de) * 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN1870995A (zh) * 2003-09-02 2006-11-29 诺瓦提斯公司 使用埃坡霉素的癌症治疗
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
KR101604864B1 (ko) * 2008-04-25 2016-03-18 에이에스엠 인터내셔널 엔.브이. 텔루르와 셀렌 박막의 원자층 증착을 위한 전구체의 합성과 그 용도
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
WO2011056519A2 (en) 2009-10-26 2011-05-12 Asm International N.V. Synthesis and use of precursors for ald of group va element containing thin films
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
AU738576B2 (en) * 1997-12-04 2001-09-20 Bristol-Myers Squibb Company A process for the reduction of oxiranyl epothilones to olefinic epothilones
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
CN100381566C (zh) * 1998-11-20 2008-04-16 科森生物科学公司 产生环氧噻酮及其衍生物的重组方法和材料
ES2273688T3 (es) * 1999-04-14 2007-05-16 Dana-Farber Cancer Institute, Inc. Procedimiento y composicion para el tratamiento de cancer.
WO2001064650A2 (en) * 2000-03-01 2001-09-07 Sloan-Kettering Institute For Cancer Research Center Synthesis of epothilones, intermediates thereto and analogues thereof
WO2001083800A2 (en) * 2000-04-28 2001-11-08 Kosan Biosciences, Inc. Heterologous production of polyketides
AU7902501A (en) * 2000-07-25 2002-02-05 Kosan Biosciences Inc Fermentation process for epothilones

Also Published As

Publication number Publication date
WO2004103267A2 (en) 2004-12-02
JP2006514681A (ja) 2006-05-11
WO2004103267A3 (en) 2008-11-27
AU2003296878A8 (en) 2009-01-08
KR20050043796A (ko) 2005-05-11
EP1575556A2 (en) 2005-09-21
US20040072882A1 (en) 2004-04-15
CN101389334A (zh) 2009-03-18

Similar Documents

Publication Publication Date Title
AU2003901345A0 (en) Improved cannula
AU2003239909A1 (en) Enhanced-service provision
AU2002329877A1 (en) Cross reference to related art
AU2003215209A1 (en) Syringe
AU2003259457A1 (en) Auto-destructible syringe
AU2003291889A1 (en) Footing form
AU2003283626A1 (en) Catheter
AU2003296878A8 (en) Methods to administer epothilone d
AU2003218107A1 (en) C12-cyano epothilone derivatives
AU2003294938A1 (en) Epothilone derivatives
AUPS239302A0 (en) Improvements to tow-bars
AU2003244140A1 (en) Catheter
AU2003255727A1 (en) Syringes
AU2003255139A1 (en) Tractor
AU2003264722A1 (en) Methods
AU2003292682A1 (en) Catheter
AU2003211854A1 (en) Putter
AU2003255137A1 (en) Tractor
AU2003255136A1 (en) Tractor
AU2003253735A1 (en) Vacuolins
AU2003268985A1 (en) Cannula
AU2003231937A1 (en) Therapeutic methods
AU2003255138A1 (en) Tractor
AU2003255140A1 (en) Tractor
AU2003253469A1 (en) Putter

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase